key: cord-0991725-bisxa8mb
authors: Beltrán‐Corbellini, Álvaro; Chico‐García, Juan Luís; Martínez‐Poles, Javier; Rodríguez‐Jorge, Fernando; Alonso‐Cánovas, Araceli
title: Reply to letter: Acute‐onset smell and taste disorders in the context of Covid‐19: a pilot multicenter PCR‐based case‐control study
date: 2020-05-25
journal: Eur J Neurol
DOI: 10.1111/ene.14359
sha: e124af73de834fd73131e570899203ce56c272ed
doc_id: 991725
cord_uid: bisxa8mb

We thank our colleagues for their constructive discussion on our recently published study(1). Regarding prevalence, indeed, growing literature yields a variable frequency of loss of smell (LOS) in Covid‐19 patients, that may be hypothetically due to differences in the location and amount of viral load, to the different immune response between younger mild‐symptomatic outpatients (higher prevalence) and more severely affected inpatients (lower prevalence)(1,2), and to the variable methods of measurement.

This article is protected by copyright. All rights reserved Dear Editor, We thank our colleagues for their constructive discussion on our recently published study 1 .

Regarding prevalence, indeed, growing literature yields a variable frequency of loss of smell (LOS)

in Covid-19 patients, that may be hypothetically due to differences in the location and amount of viral load, to the different immune response between younger mild-symptomatic outpatients (higher prevalence) and more severely affected inpatients (lower prevalence) 1,2 , and to the variable methods of measurement.

Likewise, there may be a mismatch between self-reported and objective LOS, both over and underestimation 3 . Standardised objective measurements are necessary for an accurate

This article is protected by copyright. All rights reserved description of the syndrome, but we believe self-reported LOS analysis is very relevant, and pragmatically more useful in a real-life setting.

As for the low prevalence and/or lack of association of nasal obstruction with LOS, several previous reports 2,4 agree with our own findings, suggesting it is likely the olfactory neuroepithelium damage the responsible for this sensory loss. Certainly, further investigation is warranted to confirm this 5 .

Finally, we agree that we assumed a recall bias regarding our historical control sample of influenza. Unfortunately, during the maximum incidence of Covid-19, there were not enough truly reliable SARS-CoV-2-PCR-negative patients, nor admissions for other respiratory infections in our centers.

The authors declare no financial or other conflicts of interest.

Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study

Objective olfactory testing in patients presenting with sudden onset olfactory dysfunction as the first manifestation of confirmed COVID-19 infection

Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease

Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol